This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2006.09.014v1 48/9_Suppl_A/A79    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Richard, P. Articles by Isnard, R. Search for Related Content PubMed Articles by Richard, P. Articles by Isnard, R.

STATE-OF-THE-ART PAPER

The Genetic Bases of Cardiomyopathies

Pascale Richard, MD, PhD^,, Eric Villard, PhD^||, Philippe Charron, MD, PhD^_*,,|| and Richard Isnard, MD^_*,,_*

^_* Institut de Cardiologie, Unité Fonctionnelle de Cardiogénétique et Myogénétique, Paris, France
Fédération de Biochimie, Unité Fonctionnelle de Cardiogénétique et Myogénétique, Paris, France
Département de Génétique, Centre Hospitalo-Universitaire Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France
INSERM U 582, Centre Hospitalo-Universitaire Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France
^|| INSERM U621, Centre Hospitalo-Universitaire Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.

Manuscript received August 4, 2006; revised manuscript received September 15, 2006, accepted September 15, 2006.

^_* Reprint requests and correspondence: Dr. Richard Isnard, Institut de Cardiologie, Centre Hospitalo-Universitaire Pitié-Salpêtrière, 47-83 Boulevard de l’Hôpital, 75651 Paris Cedex 13, France. (Email: richard.isnard{at}psl.aphp.fr).

Cardiomyopathies represent an important cause of cardiovascular morbidity and mortality due to heart failure, arrhythmias, and sudden death. A majority of hypertrophic cardiomyopathies (HCM) and at least 30% of dilated cardiomyopathies (DCM) are familial forms, with most often an autosomal dominant mode of inheritance. Over the last 15 years, our knowledge on the genetic bases of these diseases has considerably improved. Cardiomyopathies are characterized by a great genetic heterogeneity at both allelic and non-allelic levels. Hypertrophic cardiomyopathies are mainly linked to mutations on genes encoding sarcomeric proteins, and beta myosin heavy chain and myosin binding protein C gene mutations account for about 80% of genotyped cases. Familial DCM is associated with mutations in genes encoding sarcomeric proteins but also other proteins of the myocyte, such as cytoskeletal or nuclear membrane proteins. Due to the genetic heterogeneity and the variable clinical expressivity of these diseases, the relations between genotype and phenotype remain complex, but the age of onset, the clinical severity, or associated phenotypes may be, at least in part, related to the precise gene mutations. Therefore, besides a better understanding of the molecular basis for cardiac remodeling and heart failure, the genetic analysis of cardiomyopathies is going to play an increasing role in the routine management of these patients in the following years, particularly in HCM.

Abbreviations and Acronyms   ATP = adenosine triphosphate   DCM = dilated cardiomyopathy   HCM = hypertrophic cardiomyopathy   LVH = left ventricular hypertrophy

This article has been cited by other articles:

				F. W. Friedrich, P. Bausero, Y. Sun, A. Treszl, E. Kramer, D. Juhr, P. Richard, K. Wegscheider, K. Schwartz, D. Brito, et al. A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy Eur. Heart J., July 1, 2009; 30(13): 1648 - 1655. [Abstract] [Full Text] [PDF]

				R. E. Hershberger, J. Cowan, A. Morales, and J. D. Siegfried Progress With Genetic Cardiomyopathies: Screening, Counseling, and Testing in Dilated, Hypertrophic, and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circ Heart Fail, May 1, 2009; 2(3): 253 - 261. [Abstract] [Full Text] [PDF]

				M. Emdin, S. Vittorini, C. Passino, and A. Clerico Old and new biomarkers of heart failure Eur J Heart Fail, April 1, 2009; 11(4): 331 - 335. [Abstract] [Full Text] [PDF]

				A. Rudolph, H. Abdel-Aty, S. Bohl, P. Boye, A. Zagrosek, R. Dietz, and J. Schulz-Menger Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J. Am. Coll. Cardiol., January 20, 2009; 53(3): 284 - 291. [Abstract] [Full Text] [PDF]

				C. Geier, K. Gehmlich, E. Ehler, S. Hassfeld, A. Perrot, K. Hayess, N. Cardim, K. Wenzel, B. Erdmann, F. Krackhardt, et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy Hum. Mol. Genet., September 15, 2008; 17(18): 2753 - 2765. [Abstract] [Full Text] [PDF]

				B. Liang, F. Chung, Y. Qu, D. Pavlov, T. E. Gillis, S. B. Tikunova, J. P. Davis, and G. F. Tibbits Familial hypertrophic cardiomyopathy-related cardiac troponin C mutation L29Q affects Ca2+ binding and myofilament contractility Physiol Genomics, April 1, 2008; 33(2): 257 - 266. [Abstract] [Full Text] [PDF]

				L. Duboscq-Bidot, P. Xu, P. Charron, N. Neyroud, G. Dilanian, A. Millaire, V. Bors, M. Komajda, and E. Villard Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy Cardiovasc Res, January 1, 2008; 77(1): 118 - 125. [Abstract] [Full Text] [PDF]